Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic polymorphisms and rocuronium duration of action study
ChiCTR-RPR-15007205Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rocuronium, sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Time-course of action and Genotype. Started May 2014; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on ChiCTR-RPR-15007205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RPR-15007205.